![](/img/cover-not-exists.png)
Phase II trial of weekly docetaxel (D) in second-line non-small cell lung cancer (NSCLC)
Lilenbaum, R, Schwartz, M, Siegel, L, Belette, F, Blaustein, A, Wittlin, F, Cisneros, N, Davila, EVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80139-7
Date:
September, 2000
File:
PDF, 114 KB
english, 2000